Identifying Small Molecule Inhibitors of SLC38A2/SNAT2 to Treat Pancreatic Cancer 2022 Drug Discovery Award Alec Kimmelman, MD, PhD, New York University; Seth Parker, PhD, University of British Columbia Read More
Developing CDK11 Inhibition as a Novel Anti-Cancer Strategy 2022 Drug Discovery Award Jason Sheltzer PhD, Yale University; Jane Endicott, PhD, Newcastle University Read More
Somatic Modeling of Estrogen-Receptor-Positive Breast Cancer in Rats 2022 ASPIRE Award Jos Jonkers, PhD, Netherlands Cancer Institute, The Netherlands Read More
Developing Genetic Models for Studying Cardinal Features of Human Cancer 2022 ASPIRE Award Nikhil Joshi, PhD, Yale University Read More
Parallel Molecular and Functional Dissection of Cancer Cell States in Human Solid Tumors 2022 ASPIRE Award Tuomas Tammela, MD, PhD; Dana Pe’er, PhD; Rui Gardner, PhD, Memorial Sloan Kettering Cancer Center Read More
The Microbiome of Glioblastoma Multiforme and the Normal Brain: Characterization and Translational Opportunities 2022 PARTNERSHIP WITH THE ISRAEL CANCER RESEARCH FUND Ravid Straussman, MD, PhD, Weizmann Institute of Science, Israel Read More